Upgrade to SI Premium - Free Trial

Nektar Therapeutics (NKTR) PT Raised to $150 at Jefferies

April 22, 2026 12:21 PM
Jefferies analyst Roger Song raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $150.00 (from $121.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change